Caxton Associates (New York)’s Omeros OMER Stock Holding History

Caxton Associates (New York)’s Portfolio OMER Stock Details OMER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-12,737	Closed	-$227K	–	568
2021 Q1	$227K	Buy	+12,737	New	+$248K	0.02%	350

Other funds holding OMER

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

Caxton Associates (New York)'s OMER Position: Q2 2021 in Review

Caxton Associates (New York) sold out of Omeros (OMER) in Q2 2021, closing a stake of 12,737 shares — an estimated $227K sold.

Caxton Associates (New York) first reported a position in OMER in Q1 2021 and held it in 1 quarter. The position peaked at $227K in Q1 2021. 152 funds tracked by Wall St. Rank hold OMER as of Q2 2021.

Caxton Associates (New York) reported no remaining Omeros position as of Q2 2021 after selling out during the quarter.
Caxton Associates (New York) sold 12,737 Omeros shares in Q2 2021, an estimated $227K.
Caxton Associates (New York) first reported a position in Omeros in Q1 2021 and held it in 1 quarter.
Caxton Associates (New York)'s Omeros position peaked at $227K in Q1 2021.
152 funds tracked by Wall St. Rank held Omeros as of Q2 2021.

Based on Caxton Associates (New York)'s 13F filing for Q2 2021, filed 16 Aug 2021.